Reports Q1 revenue $1.32B, consensus $1.27B. “We are pleased with our first quarter performance,” said President and Chief Executive Officer of Encompass Health Mark Tarr. “Revenue growth of 13.4% driven primarily by strong discharge growth combined with prudent expense management to drive Adjusted EBITDA growth of 19.2%. Our value proposition and operating strategy continue to be validated and we remain highly optimistic about the long-term prospects of our business.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EHC:
- Encompass Health (EHC) Q1 Earnings Cheat Sheet
- Encompass Health to build 50-bed rehabilitation hospital in San Antonio
- Encompass Health price target raised to $101 from $95 at Barclays
- Encompass Health Clarifies Financial Reporting and 2024 Costs
- Encompass Health backs FY24 adjusted EPS view $3.77-$4.06, consensus $3.97
